The use of 123 I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a predictor of mortality and potentially fatal events in patients with Heart Failure (HF). The standardized technique includes an early acquisition (15 minutes from injection), and a late acquisition (240 minutes) Early images mainly represent interstitial uptake, whereas delayed images represent actual neuronal uptake, however, it is reasonable to affirm that different pathological situations, such as PD and HF, imply a different meaning for early and late imaging.

Usefulness of 5 minutes 123I-mIBG scan in Parkinson's disease and heart failure / Frantellizzi, Viviana; Ricci, Maria; Farcomeni, Alessio; Pontico, Mariano; Pani, Arianna; Vincentis, Giuseppe De. - In: CURRENT RADIOPHARMACEUTICALS. - ISSN 1874-4710. - 13:(2020). [10.2174/1874471013666200127122033]

Usefulness of 5 minutes 123I-mIBG scan in Parkinson's disease and heart failure

Frantellizzi, Viviana;Ricci, Maria;Farcomeni, Alessio;Pontico, Mariano;Vincentis, Giuseppe De
2020

Abstract

The use of 123 I-mIBG has been approved for decades for Parkinson's disease (PD) diagnosis and as a predictor of mortality and potentially fatal events in patients with Heart Failure (HF). The standardized technique includes an early acquisition (15 minutes from injection), and a late acquisition (240 minutes) Early images mainly represent interstitial uptake, whereas delayed images represent actual neuronal uptake, however, it is reasonable to affirm that different pathological situations, such as PD and HF, imply a different meaning for early and late imaging.
2020
Acquisition technique; acquisition timing; cardiac sympathetic activity; heart failure; I-mIBG imaging; Parkinson's disease
01 Pubblicazione su rivista::01a Articolo in rivista
Usefulness of 5 minutes 123I-mIBG scan in Parkinson's disease and heart failure / Frantellizzi, Viviana; Ricci, Maria; Farcomeni, Alessio; Pontico, Mariano; Pani, Arianna; Vincentis, Giuseppe De. - In: CURRENT RADIOPHARMACEUTICALS. - ISSN 1874-4710. - 13:(2020). [10.2174/1874471013666200127122033]
File allegati a questo prodotto
File Dimensione Formato  
DeVincentis_Parkinson's-disease.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 269.92 kB
Formato Adobe PDF
269.92 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1364439
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact